BIOTRONIK is releasing in Europe its AlCath Flutter Gold ablation catheter that was specifically designed to help treat atrial flutter.
The gold-tipped catheter provides excellent electrical conductivity and, thanks to high density braiding and lateral stabilization of the tip, makes it easier to get to treatment site and precisely remove the unwanted tissue.
From the announcement:
BIOTRONIK pioneered GoldTip ablation in 2003 and at the time was the first and only company to advance this type of ablation technology. In developing the AlCath Flutter Gold, BIOTRONIK focused on refined control and superior stability while maintaining the core features of previous successful catheter generations.
According to Professor Lewalter, an internationally renowned leader for the treatment of arrhythmia and ablation therapy, the first use of the new AlCath Flutter Gold to treat atrial flutter was an overwhelming success.
“The superior control offered by this new ablation catheter provides me with greater precision,” said Prof. Lewalter. “While BIOTRONIK’s AlCath Gold series has always offered efficiency and safety in various tachycardia treatments, the advanced stability of this new catheter makes it optimal for treating atrial flutter. Now I can ablate with effective contact force, even in the most challenging target sites of the tricuspid isthmus anatomy.”
Press release: BIOTRONIK’s launch of AlCath® Flutter Gold advances the treatment of atrial flutter with high-end stability in clinical practice…